logo-loader
viewOptiBiotix Health PLC

OptiBiotix Health launches new fibres, minerals blend for gut microbiome health

WellBiome is an evolution of SlimBiome, a functional ingredient sold in more than 70 countries formulated to support weight loss and weight management

OptiBiotix Health PLC - OptiBiotix Health launches new fibres, minerals blend for gut microbiome health

OptiBiotix Health PLC (LON:OPTI) has announced the launch of WellBiome, a blend of fibres and minerals to promote the diversity of the gut microbiome.

The life sciences firm said it is an evolution of its SlimBiome product, which is a functional ingredient sold in more than 70 countries formulated to support weight loss and weight management.

READ: OptiBiotix Health business inks UK distribution deal for two key products

The group noted that WellBiome provides a scientifically formulated, patented and trademarked solution for partners to either enter into, or extend, their product value proposition into the wellness market using functional ingredients to improve immune, digestive, heart or metabolic health.

The AIM-quoted company noted that a recent NutritionInsight expert roundtable discussion concluded that the pandemic has prompted a significant focus on health and wellbeing amongst consumers.

Topics such as immune health and staying healthy are all at the forefront of minds at present and broader issues such as gut health, tackled by WellBiome, and weight management, tackled by SlimBiome, are of increased interest to consumers, it added.

OptiBiotix said that the health & wellness industry was estimated to be worth US$4.2 trillion in 2019 with the digestive health segment accounting for US$60bn, while an estimate from Global Market Insights said the global prebiotics market will reach US$7.2bn by 2024, up from US$3.4bn in 2016.

“Consumer understanding and interest in the microbiome is growing rapidly, particularly in the US, and this is creating a market opportunity that is large and expanding,” Optobiotix chief executive Stephen O'Hara said in statement.

“The development of functional ingredients like WellBiome, backed by science and clinical studies and protected by a broad IP portfolio,  allows OptiBiotix and its partners to access this large and growing health and wellbeing trend,” he added.

Quick facts: OptiBiotix Health PLC

Price: 52.41 GBX

AIM:OPTI
Market: AIM
Market Cap: £46.09 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of OptiBiotix Health PLC named herein, including the promotion by the Company of OptiBiotix Health PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

OptiBiotix Health CEO updates on new deal with Actial Farmaceutica and...

OptiBiotix Health's (LON:OPTI) Stephen O'Hara caught up with Proactive London's Andrew Scott following the news they've signed a distribution deal covering Australia, New Zealand, Indonesia, and Thailand for its cholesterol and blood pressure reducing dietary supplements, CholBiome and CholBiome...

1 week, 5 days ago

2 min read